158 related articles for article (PubMed ID: 27631333)
21. Growth hormone isoforms in acromegalic patients before and after treatment with octreotide LAR.
Lima GA; Wu Z; Silva CM; Barbosa FR; Dias JS; Schrank Y; Strasburger CJ; Gadelha MR
Growth Horm IGF Res; 2010 Apr; 20(2):87-92. PubMed ID: 19884028
[TBL] [Abstract][Full Text] [Related]
22. Transsphenoidal surgery in a patient with acromegaly and McCune-Albright syndrome: application of neuronavigation.
Dou W; Lin N; Ma W; Yang Y; Zhu H; Sun J; Lian W; Yang Z; Li W; Wang R
J Neurosurg; 2008 Jan; 108(1):164-9. PubMed ID: 18173327
[TBL] [Abstract][Full Text] [Related]
23. Acromegaly accompanied by Turner syndrome with 47,XXX/45,X/46,XX mosaicism.
Yamazaki M; Sato A; Nishio S; Takeda T; Miyamoto T; Katai M; Hashizume K
Intern Med; 2009; 48(6):447-53. PubMed ID: 19293545
[TBL] [Abstract][Full Text] [Related]
24. Octreotide as primary therapy for acromegaly.
Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
[TBL] [Abstract][Full Text] [Related]
25. The combination of acromegaly and Klinefelter syndrome in one patient.
Ságová I; Pávai D; Kantárová D; Vaňuga A; Sadloňová J; Vaňuga P; Dragula M
Vnitr Lek; 2019; 65(1):51-54. PubMed ID: 30823838
[TBL] [Abstract][Full Text] [Related]
26. Manifestation of rheumatoid arthritis after transsphenoidal surgery in a patient with acromegaly.
Miyoshi T; Otsuka F; Kawabata T; Inagaki K; Mukai T; Kawashima M; Ogura T; Yamamura M; Sei T; Makino H
Endocr J; 2006 Oct; 53(5):621-5. PubMed ID: 16896264
[TBL] [Abstract][Full Text] [Related]
27. The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients.
Huan C; Cui G; Ren Z
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):713-8. PubMed ID: 25796163
[TBL] [Abstract][Full Text] [Related]
28. Coexistence of ectopic pituitary adenoma and empty sella in a patient with acromegaly : a case report and review of literature.
Hong JF; Ding XH; Wang SS
Neurol India; 2012; 60(3):304-6. PubMed ID: 22824688
[TBL] [Abstract][Full Text] [Related]
29. Gigantism: X-linked acrogigantism and GPR101 mutations.
Iacovazzo D; Korbonits M
Growth Horm IGF Res; 2016; 30-31():64-69. PubMed ID: 27743704
[TBL] [Abstract][Full Text] [Related]
30. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.
Edo N; Morita K; Suzuki H; Takeshita A; Miyakawa M; Fukuhara N; Nishioka H; Yamada S; Takeuchi Y
Endocr J; 2016 May; 63(5):469-77. PubMed ID: 26949262
[TBL] [Abstract][Full Text] [Related]
31. Thyrotropin secreting pituitary adenoma accompanying a silent somatotropinoma.
Berker D; Isik S; Aydin Y; Tutuncu Y; Akdemir G; Ozcan HN; Guler S
Turk Neurosurg; 2011; 21(3):403-7. PubMed ID: 21845579
[TBL] [Abstract][Full Text] [Related]
32. Follow-up of pregnancy in acromegalic women: different presentations and outcomes.
Atmaca A; Dagdelen S; Erbas T
Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):135-9. PubMed ID: 16636980
[TBL] [Abstract][Full Text] [Related]
33. AIP mutation identified in a patient with acromegaly caused by pituitary somatotroph adenoma with neuronal choristoma.
Nishizawa H; Fukuoka H; Iguchi G; Inoshita N; Yamada S; Takahashi Y
Exp Clin Endocrinol Diabetes; 2013 May; 121(5):295-9. PubMed ID: 23674160
[TBL] [Abstract][Full Text] [Related]
34. Coexisting diseases modifying each other’s presentation - lack of growth failure in Turner syndrome due to the associated pituitary gigantism.
Dragović T; Đuran Z; Jelić S; Marinković D; Kiković S; Kuzmić-Janković S; Hajduković Z
Vojnosanit Pregl; 2016 Oct; 73(10):961-6. PubMed ID: 29328563
[TBL] [Abstract][Full Text] [Related]
35. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
[TBL] [Abstract][Full Text] [Related]
36. Combined acromegaly and subclinical Cushing disease related to high-molecular-weight adrenocorticotropic hormone.
Oki K; Yamane K; Oda Y; Kamei N; Watanabe H; Tominaga A; Amatya VJ; Oki Y; Kohno N
J Neurosurg; 2009 Feb; 110(2):369-73. PubMed ID: 18991502
[TBL] [Abstract][Full Text] [Related]
37. Novel use of endogenous GH-measurement directly after transsphenoidal microsurgery in acromegaly treated with pegvisomant.
Lüdecke DK; Crock PA; Bidlingmaier M; Schuppert F
Exp Clin Endocrinol Diabetes; 2013 Aug; 121(8):509-12. PubMed ID: 23765756
[TBL] [Abstract][Full Text] [Related]
38. [Old phenotype and new genotypes. Pituitary adenomas].
Gérard C; Jedidi H; Petrossians P; Krzesinski F; Daly A; Beckers A
Rev Med Liege; 2015 Nov; 70(11):569-74. PubMed ID: 26738269
[TBL] [Abstract][Full Text] [Related]
39. Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma.
Nasr C; Mason A; Mayberg M; Staugaitis SM; Asa SL
J Clin Endocrinol Metab; 2006 Dec; 91(12):4776-80. PubMed ID: 16968791
[TBL] [Abstract][Full Text] [Related]
40. Pituitary gigantism: Causes and clinical characteristics.
Rostomyan L; Daly AF; Beckers A
Ann Endocrinol (Paris); 2015 Dec; 76(6):643-9. PubMed ID: 26585365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
